Overview

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Vitamin D supplementation reduces the symptoms of muscle stiffness and joint tenderness that some patients may develop after starting therapy with Anastrozole for breast cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
AstraZeneca
Treatments:
Anastrozole
Calcium
Calcium Carbonate
Calcium, Dietary
Ergocalciferols
Vitamin D
Vitamins